Conference
Association of pain and quality of life (QOL) response with PSA response and survival of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) treated with docetaxel or mitoxantrone in the TAX-327 study.
Authors
Berthold DR; Pond G; De Wit R; Eisenberger MA; Tannock IF
Volume
24
Pagination
pp. 221S-221S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2006
Name of conference
42nd Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
Atlanta, GA
Conference start date
June 2, 2006
Conference end date
June 6, 2006
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X